Showing results (141-150 of 219) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2013
Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysisMadan Jagasia, Hildegard Greinix, Marie Robin, et al.
Investigational New Drugs|April 22, 2008
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemiaWendy Stock, Samir D Undevia, Carol Bivins, et al.
The Lancet. Haematology|December 22, 2015
Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 studyCourtney D DiNardo, Naval Daver, Elias Jabbour, et al.
American Journal of Hematology|September 28, 2016
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemiasBrittany Knick Ragon, Hagop Kantarjian, Elias Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2021
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia ChromosomeKiyomi Morita, Elias Jabbour, Farhad Ravandi, et al.
Blood|May 24, 2008
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cellsMohammad Luqman, Sha Klabunde, Karen Lin, et al.
Frontiers in Oncology|October 16, 2018
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaPrajwal Boddu, Gautam Borthakur, Mythili Koneru, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2014
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemiaAlfonso Quintás-Cardama, Naval Daver, Hawk Kim, et al.
Experimental Hematology|May 14, 2024
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapyDavid M Foureau, Fei Guo, Nury M Steuerwald, et al.
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
Pageof 22